Plus Therapeutics Announces Share Repurchase Program
AUSTIN, Texas, Aug. 15, 2022 -- Plus Therapeutics, Inc. , a clinical-stage pharmaceutical company developing innovative, targeted radiotherapeutics for rare and difficult-to-treat cancers, today... | August 15, 2022
Source: marketscreener.com